VRCA

SEC source: 0001579649-26-000005 · form4-08182026_050809.xml · nonDerivative · entry 2

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,587

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001556327-26-000003 · form4-08182026_050806.xml · nonDerivative · entry 1

Kirby John J. · CIK 0001556327 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,962

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.85 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002046750-26-000004 · form4-08182026_050804.xml · nonDerivative · entry 1

Zawitz David · CIK 0002046750 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $5.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002043558-26-000005 · form4-08182026_050802.xml · nonDerivative · entry 2

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,593

SEC source: 0001579649-26-000005 · form4-08182026_050809.xml · nonDerivative · entry 1

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,557

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002043558-26-000005 · form4-08182026_050802.xml · nonDerivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,593

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0002046750-26-000002 · form4-06092026_040612.xml · derivative · entry 1

Zawitz David · CIK 0002046750 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,340

Underlying: Common Stock · 171,340 shares

Expires 2035-12-23

F1 · date: The option grant was approved by a committee of the Issuer's board of directors on December 23, 2025, subject to shareholder approval of an amendment to the Issuer's 2018 Equity Incentive Plan under which the option was granted. The Issuer's shareholders approved the amendment on June 5, 2026.

F2 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $15.00, and 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $25.00, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0002043558-26-000002 · form4-06092026_040610.xml · derivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,269

Underlying: Common Stock · 512,269 shares

Expires 2035-12-23

F1 · date: The option grant was approved by a committee of the Issuer's board of directors on December 23, 2025, subject to shareholder approval of an amendment to the Issuer's 2018 Equity Incentive Plan under which the option was granted. The Issuer's shareholders approved the amendment on June 5, 2026.

F2 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $15.00, and 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $25.00, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0001814338-26-000002 · form4-06092026_040603.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001579649-26-000002 · form4-06092026_040614.xml · derivative · entry 1

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,840

Underlying: Common Stock · 233,840 shares

Expires 2035-12-23

F1 · date: The option grant was approved by a committee of the Issuer's board of directors on December 23, 2025, subject to shareholder approval of an amendment to the Issuer's 2018 Equity Incentive Plan under which the option was granted. The Issuer's shareholders approved the amendment on June 5, 2026.

F2 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $15.00, and 50% of the total shares subject to the option shall vest on the date that the closing sales price per share of the Issuer's Common Stock as reported on The Nasdaq Capital Market equals at least $25.00, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0001814892-26-000002 · form4-06092026_040606.xml · derivative · entry 1

Eichenfield Lawrence · CIK 0001814892 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001257544-26-000002 · form4-06092026_040601.xml · derivative · entry 1

PRYGOCKI MARK A SR · CIK 0001257544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001745995-26-000002 · form4-06092026_040608.xml · derivative · entry 1

Corcoran Gavin · CIK 0001745995 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001556327-25-000006 · form4-12302025_081201.xml · nonDerivative · entry 1

Kirby John J. · CIK 0001556327 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,962

F1 · shares: Represents a fully vested restricted stock unit award.

SEC source: 0002046750-25-000004 · form4-11252025_071109.xml · derivative · entry 2

Zawitz David · CIK 0002046750 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2030-11-25

F3 · price: The reported securities are included within 10,000 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0002046750-25-000004 · form4-11252025_071109.xml · nonDerivative · entry 1

Zawitz David · CIK 0002046750 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

F1 · balance_after: Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

SEC source: 0002043558-25-000003 · form4-11252025_071107.xml · derivative · entry 6

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,577

Underlying: Common Stock · 23,577 shares

Expires 2030-11-25

F4 · price: The reported securities are included within 94,311 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F3 · derivative.exercise_date: Immediately exercisable.

SEC source: 0002043558-25-000003 · form4-11252025_071107.xml · nonDerivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,593

F1 · balance_after: Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

SEC source: 0001579649-25-000004 · form4-11252025_071113.xml · derivative · entry 2

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 589

Underlying: Common Stock · 589 shares

Expires 2030-11-25

F2 · price: The reported securities are included within 2,357 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F1 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001579649-25-000004 · form4-11252025_071113.xml · nonDerivative · entry 1

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,357

SEC source: 0001556327-25-000004 · form4-11252025_071111.xml · derivative · entry 2

Kirby John J. · CIK 0001556327 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 884

Underlying: Common Stock · 884 shares

Expires 2030-11-25

F3 · price: The reported securities are included within 3,536 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F2 · derivative.exercise_date: Immediately exercisable.

SEC source: 0001556327-25-000004 · form4-11252025_071111.xml · nonDerivative · entry 1

Kirby John J. · CIK 0001556327 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,962

F1 · balance_after: Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

SEC source: 0001494695-25-000004 · form4-11252025_071105.xml · derivative · entry 9

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 687,690

Underlying: Common Stock · 687,690 shares

Expires 2030-11-25

F9 · price: The reported securities are included within 2,750,762 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F7 · derivative.exercise_date: Immediately exercisable.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.

SEC source: 0001494695-25-000004 · form4-11252025_071105.xml · derivative · entry 8

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,845

Underlying: Common Stock · 343,845 shares

Expires 2030-11-25

F8 · price: The reported securities are included within 1,375,380 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F7 · derivative.exercise_date: Immediately exercisable.

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

SEC source: 0001494695-25-000004 · form4-11252025_071105.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 3,348,372

F1 · balance_after: Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

F3 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.

SEC source: 0001494695-25-000004 · form4-11252025_071105.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,958,189

F1 · balance_after: Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

SEC source: 0001415889-25-016288 · form4-06092025_040603.xml · derivative · entry 1

Nguyen Diem · CIK 0001814338 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001415889-25-016290 · form4-06092025_040607.xml · derivative · entry 1

Corcoran Gavin · CIK 0001745995 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001415889-25-016287 · form4-06092025_040601.xml · derivative · entry 1

Eichenfield Lawrence · CIK 0001814892 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001415889-25-016289 · form4-06092025_040605.xml · derivative · entry 1

PRYGOCKI MARK A SR · CIK 0001257544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2035-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.

SEC source: 0001415889-25-009654 · form4-04022025_080448.xml · derivative · entry 1

Corcoran Gavin · CIK 0001745995 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,502

Underlying: Common Stock · 17,502 shares

Expires 2035-03-31

F1 · derivative.exercise_date: 1/3rd of the total shares subject to the option shall vest on March 31, 2026, and 1/36th of the total shares subject to the option shall vest in 24 monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001415889-25-008999 · form4-03262025_110341.xml · derivative · entry 1

Rosenberg Noah L. · CIK 0001579649 · CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,000

Underlying: Common Stock · 325,000 shares

Expires 2035-03-24

F1 · derivative.exercise_date: 1/8th of the total shares subject to the option shall vest on September 24, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001415889-25-008505 · form4-03182025_060301.xml · nonDerivative · entry 1

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,458

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the settlement of the restricted stock units. This sale was mandated by the Issuer's election under its 2018 equity incentive plan to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6378 to $0.6605 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-25-008506 · form4-03182025_060303.xml · derivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,000

Underlying: Common Stock · 850,000 shares

Expires 2035-03-14

F1 · derivative.exercise_date: 1/8th of the total shares subject to the option shall vest on September 14, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001415889-25-008505 · form4-03182025_060301.xml · derivative · entry 2

Hayes Christopher G. · CIK 0001805359 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-03-14

F3 · derivative.exercise_date: 50% of the total shares subject to the option shall vest on each of March 14, 2026 and March 14, 2027, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001415889-24-028674 · form4-12092024_101222.xml · derivative · entry 1

Zawitz David · CIK 0002046750 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 950,000

Underlying: Common Stock · 950,000 shares

Expires 2034-12-09

F1 · derivative.exercise_date: 1/8th of the total shares subject to the option shall vest on June 9, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001415889-24-027711 · form4-11262024_041106.xml · nonDerivative · entry 2

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 882,826

SEC source: 0001415889-24-027710 · form4-11262024_041104.xml · nonDerivative · entry 2

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,873,800

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · nonDerivative · entry 3

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,828,094

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

SEC source: 0001415889-24-027711 · form4-11262024_041106.xml · derivative · entry 8

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,449

Underlying: Common Stock · 140,449 shares

Expires 2029-11-22

F1 · price: The reported securities are included within 280,898 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027711 · form4-11262024_041106.xml · derivative · entry 7

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,449

Underlying: Common Stock · 140,449 shares

Expires 2025-11-22

F1 · price: The reported securities are included within 280,898 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027711 · form4-11262024_041106.xml · nonDerivative · entry 1

Rieger Jayson · CIK 0002043558 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 832,826

F1 · price: The reported securities are included within 280,898 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027710 · form4-11262024_041104.xml · derivative · entry 4

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 561,797

Underlying: Common Stock · 561,797 shares

Expires 2029-11-22

F1 · price: The reported securities are included within 1,123,595 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027710 · form4-11262024_041104.xml · derivative · entry 3

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 561,797

Underlying: Common Stock · 561,797 shares

Expires 2025-11-22

F1 · price: The reported securities are included within 1,123,595 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027710 · form4-11262024_041104.xml · nonDerivative · entry 1

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,823,800

F1 · price: The reported securities are included within 1,123,595 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · derivative · entry 12

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,247,191

Underlying: Common Stock · 2,247,191 shares

Expires 2029-11-22

F3 · price: The reported securities are included within 4,494,382 investment units purchased by BKB Growth Investments, LLC ("BKB") for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, one Series A warrant and one Series B warrant, each to purchase up to 2,247,191 shares of common stock.

F4 · ownership.nature: The shares are held directly by BKB. The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · derivative · entry 11

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,247,191

Underlying: Common Stock · 2,247,191 shares

Expires 2025-11-22

F3 · price: The reported securities are included within 4,494,382 investment units purchased by BKB Growth Investments, LLC ("BKB") for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, one Series A warrant and one Series B warrant, each to purchase up to 2,247,191 shares of common stock.

F4 · ownership.nature: The shares are held directly by BKB. The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · derivative · entry 10

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,213,483

Underlying: Common Stock · 9,213,483 shares

Expires 2029-11-22

F1 · price: The reported securities are included within 18,426,966 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock,a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · derivative · entry 9

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,213,483

Underlying: Common Stock · 9,213,483 shares

Expires 2025-11-22

F1 · price: The reported securities are included within 18,426,966 investment units purchased by the Reporting Person for $0.89 per investment unit. Each investment unit consists of one share of Common Stock,a Series A warrant for one half of a share of common stock and a Series B warrant for one half of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series A or Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

F2 · ownership.direct: The shares are held by Mr. Manning jointly with his spouse.

SEC source: 0001415889-24-027709 · form4-11262024_041101.xml · nonDerivative · entry 2

Manning Paul B · CIK 0001494695 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,976,101

F3 · price: The reported securities are included within 4,494,382 investment units purchased by BKB Growth Investments, LLC ("BKB") for $0.89 per investment unit. Each investment unit consists of one share of Common Stock, one Series A warrant and one Series B warrant, each to purchase up to 2,247,191 shares of common stock.

F4 · ownership.nature: The shares are held directly by BKB. The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.